Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
99
NCT01428726
A Phase IIa Study of NT-KO-003 for Multiple Sclerosis
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2011
Completion: Jan 31, 2014